Drugs & OTC

Queensland Bauxite Ltd (ASX:QBL) Quarterly Report

🕔8/1/2018 3:54:15 PM

Queensland Bauxite Ltd (ASX:QBL) provides the Company's Quarterly Report.

Read Full Article▸

Queensland Bauxite Ltd (ASX:QBL) Recompliance Update

🕔8/1/2018 10:07:25 AM

Further to the Transformation Announcement made on 20 June 2018, the Board of Queensland Bauxite Limited (ASX:QBL) has recognised that due to current market conditions, the intended capital raise at 8c is no longer an immediate practical option. As a result, the Board has decided to amend the raising price for the recompliance.

Read Full Article▸

The Hydroponics Company Ltd (ASX:THC) Australian Patients Can Now Access Endoca Medicinal Cannabis

🕔7/31/2018 9:53:07 AM

The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading medicinal cannabis company advises that THC's wholly owned subsidiary, Canndeo Limited, has released its first medicinal cannabis products, imported from the Company's European strategic alliance partner, Endoca.

Read Full Article▸

The Hydroponics Company Ltd (ASX:THC) Canadian Hydroponics Division and Restatement of Objectives

🕔7/30/2018 10:18:20 AM

The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading medicinal cannabis company and Biofloral Inc, a Canadian east coast hydroponics company, have chosen to work together to benefit from each other's IP and distribution networks. The proposed acquisition of BioFloral (ASX- 24 January 2018) is not proceeding.

Read Full Article▸

MMJ PhytoTech Ltd (ASX:MMJ) Portfolio Outlook

🕔7/30/2018 8:23:04 AM

MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) provides a summary of the outlook for each of its cannabis sector investments through to the end of this year.

Read Full Article▸

The Hydroponics Company Ltd (ASX:THC) Company Presentation - July 2018

🕔7/25/2018 9:44:55 AM

The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis company provides the enclosed Company Presentation updated to July 2018 in accordance with ASX Listing Rule 3.1.

Read Full Article▸

MMJ PhytoTech Ltd (ASX:MMJ) PTL Completes Phase 2 Clinical Trial

🕔7/24/2018 1:57:04 PM

MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to announce results of the Phase 2 clinical trial undertaken by its wholly-owned subsidiary PhytoTech Therapeutics Ltd. As previously announced, PTL is to be sold by MMJ to Harvest One Cannabis Inc. (CVE:HVT), subject to MMJ shareholder approval.

Read Full Article▸